Dr. Naeem-Ul-Haq Khan | Radiopharmaceuticals | Best Researcher Award

Dr. Naeem-Ul-Haq Khan is a dedicated researcher and academic specializing in Chemistry, with a focus on Radiopharmaceuticals. He holds a Ph.D. from GC University Faisalabad, Pakistan, and the University of Melbourne, Australia, where his research addressed radionuclide-labeled probes for diagnosing and treating malignant diseases. With a blend of academic and research expertise, Dr. Khan has contributed significantly to healthcare advancements. His professional journey includes roles as a researcher, postdoctoral fellow, and project leader, showcasing his ability to secure competitive funding and lead impactful studies. Dr. Khan has authored multiple peer-reviewed articles in renowned journals, presented his work at international conferences, and participated in technical workshops, underlining his commitment to continuous learning and research excellence.

Professional Profile

• Scopus Profile
• ORCID Profile
• Google Scholar

Education

Dr. Naeem-Ul-Haq Khan has an impressive academic background. He completed his Ph.D. in Chemistry, specializing in Radiopharmaceuticals, from GC University Faisalabad and the University of Melbourne in 2020. His dissertation focused on developing radionuclide-labeled probes for cancer diagnosis and therapy. He earned his M.Phil. in Chemistry from the University of Agriculture Faisalabad in 2013 and a Master’s in Chemistry from the University of Gujrat in 2009, both with first-division honors. Dr. Khan also holds a Bachelor’s degree from Punjab University, Lahore, and earlier academic certifications in Physics, Chemistry, and Mathematics with exceptional results. His consistent academic performance underscores his dedication to excellence in education.

Professional Experience

Dr. Khan’s professional career is marked by impactful roles in academia and research. He is currently a researcher in the Department of Chemistry at GC University Faisalabad. He served as a postdoctoral fellow at the National Institute for Biotechnology and Genetic Engineering (NIBGE), where he contributed to radiopharmaceutical innovation. Previously, he worked on a national project at the Pakistan Institute of Nuclear Science and Technology (PINSTECH), focusing on 177Lu-labeled kits for medical applications. Earlier in his career, he served as a College Teaching Intern, enhancing his teaching and mentoring skills. Dr. Khan’s professional journey showcases a blend of research innovation and academic contributions.

Research Interests

Dr. Khan’s research interests lie in the innovative field of radiopharmaceuticals. He focuses on developing radionuclide-labeled compounds for the early diagnosis and treatment of diseases, particularly cancer and drug-resistant infections. His work integrates chemistry, biotechnology, and medical imaging, reflecting his commitment to advancing healthcare solutions. Dr. Khan is also interested in the biological evaluation of radiolabeled molecules, the development of novel diagnostic tools, and exploring advanced oxidation processes. His interdisciplinary approach enables the translation of fundamental chemistry into impactful biomedical applications.

Research Skills

Dr. Khan possesses extensive research skills, including radiopharmaceutical synthesis, radionuclide labeling, and biological evaluations. His expertise encompasses modern analytical techniques, such as spectroscopy, chromatography, and imaging tools, to investigate radiolabeled compounds. He is skilled in designing and conducting advanced experiments in chemistry and biotechnology, with proficiency in handling radioactive materials. Additionally, Dr. Khan is experienced in scientific writing, data analysis, and technical presentations. His participation in workshops on research paper writing and analytical methods demonstrates his commitment to refining his research capabilities.

Awards and Honors

Dr. Naeem-Ul-Haq Khan has earned several prestigious awards and honors throughout his career. He was awarded the IRSIP scholarship by the Higher Education Commission (HEC) of Pakistan for advanced research at the University of Melbourne and Peter MacCallum Cancer Centre. He also secured a PKRs. 2.7 million research grant from the National Institute of Health, Islamabad, to develop radiopharmaceuticals for diagnosing infections caused by resistant pathogens. These achievements highlight his ability to attract competitive funding and contribute to cutting-edge research. His academic and research accomplishments have positioned him as a recognized leader in radiopharmaceutical innovation.